glp 1 and osteoarthritis Targeting the GLP-1/GLP-1R axis to treat osteoarthritis: A new opportunity? Osteoarthritis treatment via the GLP-1–mediated
Description
Glp1r-Lepr coexpressing neurons modulate the suppression of food intake and body weight by a GLP-1/ leptin dual agonist
While originally approved for type 2 diabetes and cardiovascular disease, these drugs have demonstrated significant efficacy for weight loss, fueling public demand and legislative proposals to expand coverage
MAESTRO-NASH Investigators
Current concepts in the diagnosis, pathogenesis and management of nonarteritic anterior ischaemic optic neuropathy
